| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/30/2006 | US20060069026 composition of a peptide analogue of the carboxyl-terminal sequence of a growth hormone, particularly an analogue of the carboxyl-terminal sequence of human growth hormone containing amino acid residues 177-191; including cyclic peptides, or acid addition salts |
| 03/30/2006 | US20060069025 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 03/30/2006 | US20060069019 Crystal structure of the complex of hepatocyte growth factor beta chain with Met receptor and methods of use |
| 03/30/2006 | US20060069017 Somatostatin analog and uses thereof |
| 03/30/2006 | US20060068497 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
| 03/30/2006 | US20060068494 WNT4 in supporting lymphopoiesis |
| 03/30/2006 | US20060068485 Novel human synaptotagmin and polynucleotides encoding the same |
| 03/30/2006 | US20060068480 Polypeptides and polypeptide analogues |
| 03/30/2006 | US20060068478 Site specific incorporation of keto amino acids into proteins |
| 03/30/2006 | US20060068474 endothelial-monocyte activating polypeptide III (EMAP III) cDNA encoding such proteins; anticarcinogenic agent; diagnostically or therapeutically useful |
| 03/30/2006 | US20060068472 Compositions to ameliorate protein misfolding and aggregation |
| 03/30/2006 | US20060068471 Soluble zcytor 11 cytokine receptors |
| 03/30/2006 | US20060068470 Antifreeze proteins from basidiomy cetes |
| 03/30/2006 | US20060068469 Bacterial vector systems |
| 03/30/2006 | US20060068468 for modulating growth of a tissue, such as bone, cartilage, muscle, fat, and/or neuron; comprising an altered Growth differentiation factor 11 (GDF11)-binding domain of an ActRII receptor |
| 03/30/2006 | US20060068467 Rhodococcus polynucleotide cluster that contains 4 nucleotide sequences that encode 2 polypeptides having nitrile hydratase activity, an auxiliary protein P15K that activates this enzyme, and a cobalt transporter |
| 03/30/2006 | US20060068466 Used in assays for the identification of new agents for anesthesia and analgesia |
| 03/30/2006 | US20060068464 Regulation of human g protein coupled receptor |
| 03/30/2006 | US20060068463 Natural killer cell activating factor ii |
| 03/30/2006 | US20060068453 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 03/30/2006 | US20060068451 Dimeric fluorescent polypeptides |
| 03/30/2006 | US20060068448 isolated nucleic acid encoding a fungal antigen from Candida albicans; antiallergenic reaction to fungi in a vertebrate; and diagnosing a disease caused by fungi in a vertebrate; desensitization therapy for vaccines; immunosuppressants; insoluble cytoplasmic membrane proteins, free of cell wall |
| 03/30/2006 | US20060068445 Novel soluble CD14 antigen |
| 03/30/2006 | US20060068442 immunogens; tumor antigens; devoid of immunosuppressive domain; fusion proteins; immunotherapy |
| 03/30/2006 | US20060068441 Alternative pol kappa nucleotide and amino acid sequence and methods for using |
| 03/30/2006 | US20060068439 Ucp4 |
| 03/30/2006 | US20060068437 Meg-3 protein |
| 03/30/2006 | US20060068425 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 03/30/2006 | US20060068423 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068420 Regulation of Th2 cell activity by modulation of NFATp and NFAT4 activity |
| 03/30/2006 | US20060068413 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068404 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068393 Mevalonate kinase as a target for fungicides |
| 03/30/2006 | US20060068391 Contacting the target cell with a recombinant HSV particle comprising an altered gD forming a fusion with a peptide ligand to a receptor specific to the cell wherein the altered gD exhibits reduced binding to at least one of the cellular receptors of wild type gD |
| 03/30/2006 | US20060068387 Genetic marker for endocrine disorders |
| 03/30/2006 | US20060068386 Complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
| 03/30/2006 | US20060068383 Kits for the detection of target sequences |
| 03/30/2006 | US20060068382 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/30/2006 | US20060067951 Signal peptides, nucleic acid molecules and methods for treatment of caries |
| 03/30/2006 | US20060067945 Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection |
| 03/30/2006 | US20060067944 Stable immunogenic product comprising antigenic heterocomplexes |
| 03/30/2006 | US20060067934 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors |
| 03/30/2006 | US20060067933 Soluble receptor BR43x2 and methods of using |
| 03/30/2006 | US20060067929 Administering a modified Clostridial toxin with a proteolytic domain; a translocation domain and an orphanin targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction. |
| 03/30/2006 | US20060067920 Chimeric immunoreceptor useful in treating human cancers |
| 03/30/2006 | US20060067919 Colon cancer metastasis inhibitor |
| 03/30/2006 | US20060067886 Competitive binding with bombesin; radiopharmaceuticals for treatment of neoplastic diseases |
| 03/30/2006 | DE10347710B4 Rekombinante Impfstoffe und deren Verwendung Recombinant vaccines and their use |
| 03/30/2006 | DE102004044429A1 Verfahren zur Entfernung von Fibronektin aus Plasmafraktionen A method of removing fibronectin from plasma fractions |
| 03/30/2006 | DE102004044421A1 Herstellung eines von Willebrand Faktor-Präparates mit hoher spezifischer Aktivität Production of a von Willebrand factor preparation of high specific activity |
| 03/30/2006 | DE102004044419A1 Herstellung eines von Willebrand Faktor-Präparates unter Verwendung von Hydroxylapatit Production of a von Willebrand factor preparation using hydroxyapatite |
| 03/30/2006 | DE102004035606A1 Carrier für Arzneimittel zur Gewinnung der oralen Bioverfügbarkeit Carrier for drugs used for obtaining the oral bioavailability |
| 03/30/2006 | CA2798495A1 Plant cells and plants with increased tolerance to environmental stress |
| 03/30/2006 | CA2797769A1 Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions |
| 03/30/2006 | CA2619256A1 Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover |
| 03/30/2006 | CA2581423A1 Polipeptide compounds for inhibiting angiogenesis and tumor growth |
| 03/30/2006 | CA2581319A1 Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| 03/30/2006 | CA2581091A1 Mycer immortalized hepatocyte |
| 03/30/2006 | CA2580921A1 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 03/30/2006 | CA2580904A1 Modulation of flowering time and growth cessation in perennial plants |
| 03/30/2006 | CA2580881A1 Use of microproteins as tryptase inhibitors |
| 03/30/2006 | CA2580679A1 Variants and chemically-modified variants of phenylalanine ammonia-lyase |
| 03/30/2006 | CA2580620A1 Method of detecting hepatitis b virus s antigen |
| 03/30/2006 | CA2580113A1 Purification process for bacterial cytolysin |
| 03/30/2006 | CA2579905A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp |
| 03/30/2006 | CA2579800A1 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 03/30/2006 | CA2567741A1 Self-assembling nanoparticle drug delivery system |
| 03/29/2006 | EP1640456A2 Methods for transforming phaffia strains, transformed phaffia strains so obtained and recombinant dna in said methods |
| 03/29/2006 | EP1640455A1 Fluorescent protein |
| 03/29/2006 | EP1640454A1 Cd9/cd81 double-null nonhuman animal |
| 03/29/2006 | EP1640447A1 BIOACTIVE PEPTIDE-PRODUCING STRAINS OF i ENTEROCOCCUS FAECALIS /i , BIOACTIVE PEPTIDES AND APPLICATIONS THEREOF |
| 03/29/2006 | EP1640382A1 Anti-angiogenic peptides |
| 03/29/2006 | EP1640381A2 Neurotrophic growth factor |
| 03/29/2006 | EP1639141A2 Methods for treating lentivirus infections |
| 03/29/2006 | EP1639116A2 Modified fiber proteins for efficient receptor binding |
| 03/29/2006 | EP1639114A2 Chloroplast transformation of duckweed |
| 03/29/2006 | EP1639113A1 Methods and means for delaying seed shattering in plants |
| 03/29/2006 | EP1639112A2 Novel beta-actin and rps21 promoters and uses thereof |
| 03/29/2006 | EP1639103A2 Modulation of coffee flavour precursor levels in green coffee grains |
| 03/29/2006 | EP1639097A2 Methods and compositions for modulating stem cell growth and differentiation |
| 03/29/2006 | EP1639095A2 Method to increase protein production in culture |
| 03/29/2006 | EP1639091A2 Regio- and enantioselective alkane hydroxylation with modified cytochrome p450 |
| 03/29/2006 | EP1639089A2 Transcription factor |
| 03/29/2006 | EP1639081A2 Compositions and methods for regulating polysaccharides of a plant cell |
| 03/29/2006 | EP1639008A1 Ubiquitinated tnf receptor 2 and its uses |
| 03/29/2006 | EP1639007A2 Vegf traps and therapeutic uses thereof |
| 03/29/2006 | EP1639006A1 Use of a vegf receptor gene or gene product |
| 03/29/2006 | EP1639005A2 Taste receptors of the t1r family from domestic cat |
| 03/29/2006 | EP1639004A1 Fluorescein-labelled peptides |
| 03/29/2006 | EP1639003A1 Use of cardiotrophin to modulate stem cell proliferation |
| 03/29/2006 | EP1639002A2 Cytokine variant polypeptides |
| 03/29/2006 | EP1639001A1 Method for transplanting lymphohematopoietic cells into mammal |
| 03/29/2006 | EP1639000A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/29/2006 | EP1638999A2 Compositions and methods for increasing bone mineralization |
| 03/29/2006 | EP1638998A1 Isolated photoprotein bolinopsin, and the use thereof |
| 03/29/2006 | EP1638997A2 Isoforms of elf-5a: senescence-induced elf5a; wounding-induced elf-5a; growth elf-5a; and dhs |
| 03/29/2006 | EP1638996A1 Hiv immunogenic complexes |
| 03/29/2006 | EP1638995A1 Novel surface protein (hbsag) variant of hepatitis b virus |
| 03/29/2006 | EP1638994A1 Novel surface protein (hbsag) variant of hepatitis b virus |
| 03/29/2006 | EP1638993A1 Immunomodulating compositions, uses therefor and processes for their production |